This phase III trial investigates health informatics and a self-management program for improving the health of cancer survivors after stem cell transplant. After transplant many survivors may feel stressed or may be unsure of what health care they need. A self-management program called "INSPIRE," along with a personalized survivorship care plan may improve stress and health care for transplant survivors.
OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients receive immediate access to the INSPIRE online program and personalized survivorship care plan. GROUP II: Patients receive an online program linking to existing online survivor resources and a personalized survivorship care plan. Patients receive access to the INSPIRE online program after 12 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
546
Receive usual care
Receive INSPIRE and survivorship care plan
Ancillary studies
Moffitt Cancer Center
Tampa, Florida, United States
Loyola University Medical Center
Maywood, Illinois, United States
Cancer and Treatment Distress (CTXD)
Among those impaired at baseline, percent who are no longer impaired at 12 months (among those not missing either). Scores range from 0-3 and higher scores indicate higher distress. A cutoff of \>=.90 was used to categorize participants as high in distress. Participants with scores \<.90 were categorized as not distressed.
Time frame: Up to 12 months
Health Care Adherence (HCA)-Cardiometabolic
Assesses adherence to cardiometabolic surveillance in intervention participants vs. controls. Among those impaired at baseline, percent no longer impaired at 12 months. Scores range from 0-1. Higher scores indicate high adherence. A cutoff of \<.80 was used to categorize participants as low in adherence. Scores higher than .80 were classified as being adherent to cardiometabolic surveillance.
Time frame: Up to 12 months
Characteristics of Intervention Participants Who Require Telehealth Stepped Care at 6-weeks
Determine characteristics of participants who 1) do not meet criteria for adequate knowledge of cardiometabolic risks, or 2) do not report improved distress, or 3) have not logged in to the online program.
Time frame: 6-weeks after enrollment.
Health Care Adherence (HCA)-Subsequent Malignancy Screening
Assesses adherence to subsequent malignancy surveillance in intervention participants vs. controls. Among those impaired at baseline, percent no longer impaired at 12 months.
Time frame: Up to 12 months
PHQ-8 Depression
Assessed by participant questionnaire.Among those impaired (PHQ≥10) at baseline, percent no longer impaired at 12 months
Time frame: Up to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Kansas Cancer Center
Kansas City, Kansas, United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Wayne State University/Karmanos Cancer Institute
Detroit, Michigan, United States
National Marrow Donor Program
Minneapolis, Minnesota, United States
Center for International Blood and Marrow Transplant Research
Minneapolis, Minnesota, United States
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
...and 5 more locations